Device to create human platelets could transform transfusion

The successful creation of human platelets by researchers in vitro could transform the blood transfusion market. A platelet bioreactor was developed by researchers at Brigham and Women's Hospital. The device is modeled after bone marrow and can be used to treat chemotherapy and organ transplant patients, in surgeries and for emergency trauma use. The researchers expect to begin clinical testing in 2017. Story

Suggested Articles

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.